A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma

A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma

<i>Background and Objectives</i>: Complete pathological response after ipilimumab and nivolumab combination therapy in a patient with intermediate prognosis renal cell carcinoma is an uncommon finding. <i>Case presentation</i>: A 60-year-old man presented with synchronous sol...

Full description

Bibliographic Details
Main Authors: Hana Studentova, Anezka Zemankova, Martina Spisarova, Daniela Skanderova, Zbynek Tudos, Bohuslav Melichar, Vladimir Student
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Medicina
Subjects:
pathological complete response
immunotherapy
hypophysitis
renal cell carcinoma
Online Access:https://www.mdpi.com/1648-9144/58/3/336

Internet

https://www.mdpi.com/1648-9144/58/3/336

Similar Items